High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.0M
$1,001,513
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Sell to Cover
2026-03-16
$331,809
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-16 | $331,809 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Sell to Cover
2026-03-16
$489,704
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Sell to Cover
|
2026-03-16 | $489,704 | S | Form 4 |
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Equity Compensation
2025-12-18
$0
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Equity Compensation
|
2025-12-18 | $0 | M | Form 4 |
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Other
|
2025-12-18 | $151,654 | M | Form 4 |
|
CRNX
M
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
Equity Compensation
2025-12-18
$0
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Equity Compensation
|
2025-12-18 | $0 | M | Form 4 |
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
Other
|
2025-12-18 | $434,236 | M | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Struthers Richard Scott
• CEO
10b5-1 Sell
2025-09-26
$180,000
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
CEO
10b5-1 Sell
|
2025-09-26 | $180,000 | S | Form 4 |